Neutralizing antibodies against interferon-β do not predispose antibodies against natalizumab

Neurology. 2011 Feb 22;76(8):759-60. doi: 10.1212/WNL.0b013e31820d62a4.

Authors

Per Soelberg Sørensen¹, Nils Koch-Henriksen, Poul Erik Hyldgaard Jensen

Affiliation

¹ Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. pss@rh.regionh.dk

PMID: 21339504
DOI: 10.1212/WNL.0b013e31820d62a4

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal / immunology
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing / therapeutic use*
Female
Humans
Interferon-beta / immunology*
Interferon-beta / therapeutic use*
Longitudinal Studies
Male
Multiple Sclerosis / drug therapy*
Multiple Sclerosis / immunology
Natalizumab
Time Factors

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
Natalizumab
Interferon-beta